Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02247349
Title BMS-986012 in Relapsed/Refractory SCLC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung small cell carcinoma

Therapies

BMS-986012

BMS-986012 + Nivolumab

Age Groups: adult
Covered Countries USA | CAN | BEL


No variant requirements are available.